Global Sterile Surgical Catgut Market Size By Type (Catgut, Chromic Catgut), By Application (Cardiovascular Surgeries, Gynecological Surgeries), By Region, And Segment Forecasts, 2023 to 2032

The Global Sterile Surgical Catgut Market was valued at USD 652 million in 2023 and is projected to reach USD 1.02 billion by 2031, growing at a CAGR of 5.8% during the forecast period from 2023 to 2031. The market is primarily driven by the increasing number of surgical procedures globally, rising demand for absorbable sutures, and the growing prevalence of chronic diseases and trauma cases. Sterile surgical catgut, a type of absorbable suture derived from the natural collagen found in animal intestines, is widely used in internal tissue repair, especially in rapidly healing tissues.

Drivers:

Rising Number of Surgeries:

A consistent rise in surgical procedures worldwide, due to aging populations and a surge in chronic diseases such as diabetes, cardiovascular disorders, and cancer, is increasing the demand for sterile surgical catgut.

Growing Demand for Absorbable Sutures:

Absorbable sutures like catgut eliminate the need for suture removal, reducing postoperative visits and enhancing patient comfort—making them highly preferred in internal surgeries and gynecological procedures.

Expansion of Healthcare Infrastructure:

Expanding hospital networks, surgical centers, and improved access to healthcare services in developing regions are contributing to increased usage of surgical consumables, including catgut sutures.

Restraints:

Risk of Allergic Reactions and Infections:

Catgut sutures may induce immune responses or allergic reactions in certain patients. Additionally, concerns over sterilization and the use of animal-derived materials may limit adoption in specific markets.

Availability of Synthetic Alternatives:

The market faces strong competition from synthetic absorbable sutures like polyglycolic acid and polyglactin, which offer more predictable absorption rates and lower immunogenicity.

Opportunity:

Increasing Adoption in Emerging Markets:

Developing countries are experiencing a surge in healthcare investments, expanding surgical capabilities and offering lucrative opportunities for catgut suture manufacturers.

Focus on Biodegradable and Natural Sutures:

With a growing interest in biodegradable and bioabsorbable products, sterile surgical catgut sutures are gaining favor for their natural origin and cost-effectiveness in certain medical applications.

Market by System Type Insights:

The Plain Catgut segment accounted for the largest market share in 2023. Its widespread application in soft tissue repair, combined with its rapid absorption properties, makes it a preferred option in surgeries requiring short-term wound support. The Chromic Catgut segment is expected to grow significantly due to its slower absorption rate and extended tensile strength, making it suitable for deeper tissue repairs.

Market by End-use Insights:

Hospitals emerged as the dominant end-use segment in 2023, driven by the increasing volume of surgical interventions and the widespread availability of advanced suture materials. Ambulatory Surgical Centers (ASCs) are expected to witness the fastest growth, fueled by the trend toward minimally invasive outpatient procedures and faster patient turnaround.

Market by Regional Insights:

Asia-Pacific led the global sterile surgical catgut market in 2023, owing to high surgical volumes, expanding medical tourism, and growing healthcare infrastructure in countries like India and China. North America continues to show strong market performance due to well-established healthcare systems and advanced surgical practices, while Europe maintains steady growth with increasing adoption of bioabsorbable sutures.

Competitive Scenario:

Key players in the global sterile surgical catgut market include Johnson & Johnson (Ethicon), B. Braun Melsungen AG, Teleflex Incorporated, DemeTech Corporation, Medtronic plc, Peters Surgical, Smith & Nephew, Sutures India, Boston Scientific Corporation, and Lotus Surgicals. These companies focus on product innovation, geographic expansion, and strategic collaborations.

In 2023, Ethicon introduced an enhanced sterilization technique for its catgut sutures, improving shelf-life and performance.

In 2024, B. Braun expanded its suture production facility in Asia-Pacific to meet regional demand.

DemeTech launched a new line of chromic catgut sutures tailored for use in obstetrics and gynecology.

Scope of Work – Global Sterile Surgical Catgut Market

Report Metric Details

Market Size (2023) USD 652 million

Projected Market Size (2031) USD 1.02 billion

CAGR (2023–2031) 5.8%

Market Segments By Type (Plain Catgut, Chromic Catgut), By End-use (Hospitals, ASCs, Specialty Clinics)

Growth Drivers Rising number of surgeries, Demand for absorbable sutures, Expanding healthcare access

Opportunities Growth in emerging markets, Demand for biodegradable medical materials

Key Market Developments:

May 2023: Teleflex Incorporated enhanced its surgical suture portfolio with antimicrobial-coated catgut variants to reduce surgical site infections.

October 2023: Peters Surgical signed distribution agreements in Southeast Asia to increase its footprint in emerging markets.

March 2024: Lotus Surgicals announced R&D investment in improving the tensile strength and consistency of chromic catgut sutures for orthopedic use.

FAQs:

What is the current market size of the Global Sterile Surgical Catgut Market?

The market was valued at USD 652 million in 2023.

What is the major growth driver of the Global Sterile Surgical Catgut Market?

The key driver is the rising number of surgeries and demand for absorbable, biocompatible suture materials.

Which is the largest region during the forecast period in the Global Sterile Surgical Catgut Market?

Asia-Pacific holds the largest share due to high surgical volume and healthcare expansion.

Which segment accounted for the largest market share in the Global Sterile Surgical Catgut Market?

The Plain Catgut segment accounted for the largest share in 2023.

Who are the key market players in the Global Sterile Surgical Catgut Market?

Key players include Johnson & Johnson (Ethicon), B. Braun Melsungen, Teleflex, DemeTech, and Medtronic.